Dr. Munster’s clinical research’s interests are first-in human early phase clinical trials of novel compounds and alternative strategies for the treatment and prevention of cancer.
As the program leader for Development Therapeutics and the PI of a peer-reviewed basic science lab, her main focus is on translating preclinical findings into early-stage clinical trials.
Her basic research interest centers on the role of epigenetic modification in therapy resistance in breast cancer and epigenetic priming.
She is the author of the book “Twisting Fate: My Journey with BRCA — from Breast Cancer Doctor to Patient and Back”.
Hear Pamela speak at WORLDWEBFORUM 2020 as she tackles the complex issues of genetic testing for BRCA and provides thoughtful insights as to why one should pursue it.